For the year ending 2025-12-31, KURA made $67,482K in revenue. -$278,406K in net income. Net profit margin of -412.56%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 67,482 | 53,883 | ||
| General and administrative | - | 77,111 | ||
| Cost of product sales | 57 | - | ||
| Research and development | 251,074 | 169,967 | ||
| Selling, general and administrative | 119,982 | - | ||
| Total operating expenses | 371,113 | 247,078 | ||
| Loss from operations | -303,631 | -193,195 | ||
| Interest and other income, net | 26,774 | 22,849 | ||
| Interest expense | 1,512 | 1,619 | ||
| Total other income, net | 25,262 | 21,230 | ||
| Loss before income taxes | -278,369 | -171,965 | ||
| Income tax expense | 297 | 2,018 | ||
| Net loss | -278,666 | -173,983 | ||
| Unrealized gain (loss) on short-term investments | - | -2,035 | ||
| Unrealized gain on short-term investments | 260 | - | ||
| Comprehensive loss | -278,406 | -171,948 | ||
| Basic EPS | -3.18 | -2.02 | ||
| Diluted EPS | -3.18 | -2.02 | ||
| Basic Average Shares | 87,676,000 | 86,161,000 | ||
| Diluted Average Shares | 87,676,000 | 86,161,000 | ||
Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA)